T Cells and Cancer: Uncovering the Unknowns
T cells are potent cancer-killing immune cells but cancers have developed several ways to escape them. In recent years, immunotherapies such as CAR T cells and immune checkpoint inhibitors have reactivated the T cells to be effective against cancers. Understanding the interactions between cancer cells and T cells could help us develop novel therapeutics. Here we present key takeaways from the virtual AACR conference presentations that focussed on T Cells in Cancer.
GO Prime with only $1.49 now
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115